Contineum Therapeutics, Inc. Class A (CTNM) Dividend History

Contineum Therapeutics, Inc. Class A (CTNM) is a biopharmaceutical company focused on developing innovative therapies for rare and serious diseases. The company is dedicated to advancing novel treatment options through cutting-edge research and collaboration, aiming to improve patient outcomes and address unmet medical needs.

10578 Science Center Drive, Suite 200, San Diego, CA, 92121
Phone: (858) 333-5280
Website: https://www.contineum-tx.com

Dividend History

Contineum Therapeutics, Inc. Class A currently does not pay dividends

Company News

Page data last updated 07/23/2025 10:03:23 UTC